Ontology highlight
ABSTRACT:
SUBMITTER: Codini M
PROVIDER: S-EPMC6274808 | biostudies-other | 2018 Nov
REPOSITORIES: biostudies-other
Codini Michela M Conte Carmela C Cataldi Samuela S Arcuri Cataldo C Lazzarini Andrea A Ceccarini Maria Rachele MR Patria Federica F Floridi Alessandro A Mecca Carmen C Ambesi-Impiombato Francesco Saverio FS Beccari Tommaso T Curcio Francesco F Albi Elisabetta E
International journal of molecular sciences 20181101 11
Daunorubicin is an anticancer drug, and cholesterol is involved in cancer progression, but their relationship has not been defined. In this study, we developed a novel experimental model that utilizes daunorubicin, cholesterol, and daunorubicin plus cholesterol in the same cells (H35) to search for the role of nuclear lipid microdomains, rich in cholesterol and sphingomyelin, in drug resistance. We find that the daunorubicin induces perturbation of nuclear lipid microdomains, localized in the in ...[more]